Gary Gudelsky - Publications

University of Cincinnati, Cincinnati, OH 
Neuropharmacology of amphetamines

148 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Collins SA, Huff C, Chiaia N, Gudelsky GA, Yamamoto BK. MDMA Increases Excitability in the Dentate Gyrus: Role of 5HT2A Receptor Induced PGE2 Signaling. Journal of Neurochemistry. PMID 26670377 DOI: 10.1111/jnc.13493  1
2015 Collins SA, Gudelsky GA, Yamamoto BK. MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors. European Journal of Pharmacology. 761: 95-100. PMID 25936514 DOI: 10.1016/j.ejphar.2015.04.035  1
2014 Weber GF, Johnson BN, Yamamoto BK, Gudelsky GA. Effects of stress and MDMA on hippocampal gene expression. Biomed Research International. 2014: 141396. PMID 24511526 DOI: 10.1155/2014/141396  1
2014 Krishan M, Gudelsky GA, Desai PB, Genter MB. Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain. Drug Delivery. 21: 8-16. PMID 24116937 DOI: 10.3109/10717544.2013.840017  1
2013 Dave N, Gudelsky GA, Desai PB. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis. Cancer Chemotherapy and Pharmacology. 72: 349-57. PMID 23748921 DOI: 10.1007/s00280-013-2205-y  1
2013 Huff C, Bhide N, Schroering A, Yamamoto BK, Gudelsky GA. Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake. Brain Research Bulletin. 91: 52-7. PMID 23318273 DOI: 10.1016/j.brainresbull.2013.01.003  1
2013 Isom AM, Gudelsky GA, Benoit SC, Richtand NM. Antipsychotic medications, glutamate, and cell death: a hidden, but common medication side effect? Medical Hypotheses. 80: 252-8. PMID 23265349 DOI: 10.1016/j.mehy.2012.11.042  1
2013 Anneken JH, Cunningham JI, Collins SA, Yamamoto BK, Gudelsky GA. MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 58-65. PMID 23179355 DOI: 10.1007/s11481-012-9420-x  1
2012 Anneken JH, Gudelsky GA. MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus. Neuropharmacology. 63: 1022-7. PMID 22842073 DOI: 10.1016/j.neuropharm.2012.07.026  1
2012 Schaefer TL, Grace CE, Skelton MR, Graham DL, Gudelsky GA, Vorhees CV, Williams MT. Neonatal citalopram treatment inhibits the 5-HT depleting effects of MDMA exposure in rats. Acs Chemical Neuroscience. 3: 12-21. PMID 22582138 DOI: 10.1021/cn2000553  1
2012 Roenker NL, Gudelsky GA, Ahlbrand R, Horn PS, Richtand NM. Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex. Neuropharmacology. 63: 575-81. PMID 22579658 DOI: 10.1016/j.neuropharm.2012.04.032  1
2011 Roenker NL, Gudelsky G, Ahlbrand R, Bronson SL, Kern JR, Waterman H, Richtand NM. Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801. Neuroscience Letters. 500: 167-71. PMID 21699956 DOI: 10.1016/j.neulet.2011.06.011  1
2011 Darvesh AS, Carroll RT, Geldenhuys WJ, Gudelsky GA, Klein J, Meshul CK, Van der Schyf CJ. In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opinion On Drug Discovery. 6: 109-127. PMID 21532928 DOI: 10.1517/17460441.2011.547189  1
2010 Herring NR, Gudelsky GA, Vorhees CV, Williams MT. (+)-Methamphetamine-induced monoamine reductions and impaired egocentric learning in adrenalectomized rats is independent of hyperthermia. Synapse (New York, N.Y.). 64: 773-85. PMID 20698032 DOI: 10.1002/syn.20784  1
2010 Schaefer TL, Grace CE, Gudelsky GA, Vorhees CV, Williams MT. Effects on plasma corticosterone levels and brain serotonin from interference with methamphetamine-induced corticosterone release in neonatal rats. Stress (Amsterdam, Netherlands). 13: 469-80. PMID 20666642 DOI: 10.3109/10253891003786407  1
2010 Pachmerhiwala R, Bhide N, Straiko M, Gudelsky GA. Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain. European Journal of Pharmacology. 644: 67-72. PMID 20633550 DOI: 10.1016/j.ejphar.2010.07.004  1
2010 Yamamoto BK, Moszczynska A, Gudelsky GA. Amphetamine toxicities: classical and emerging mechanisms. Annals of the New York Academy of Sciences. 1187: 101-21. PMID 20201848 DOI: 10.1111/j.1749-6632.2009.05141.x  1
2010 Grace CE, Schaefer TL, Gudelsky GA, Williams MT, Vorhees CV. Neonatal methamphetamine-induced corticosterone release in rats is inhibited by adrenal autotransplantation without altering the effect of the drug on hippocampal serotonin. Neurotoxicology and Teratology. 32: 356-61. PMID 20153424 DOI: 10.1016/  1
2010 Grace CE, Schaefer TL, Herring NR, Graham DL, Skelton MR, Gudelsky GA, Williams MT, Vorhees CV. Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicology and Teratology. 32: 346-55. PMID 20096350 DOI: 10.1016/  1
2009 Bhide NS, Lipton JW, Cunningham JI, Yamamoto BK, Gudelsky GA. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Research. 1286: 32-41. PMID 19555677 DOI: 10.1016/j.brainres.2009.06.042  1
2008 Skelton MR, Able JA, Grace CE, Herring NR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT. (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks. Neuropharmacology. 55: 1121-30. PMID 18674550 DOI: 10.1016/j.neuropharm.2008.07.006  1
2008 Herring NR, Schaefer TL, Tang PH, Skelton MR, Lucot JP, Gudelsky GA, Vorhees CV, Williams MT. Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. Bmc Neuroscience. 9: 49. PMID 18513404 DOI: 10.1186/1471-2202-9-49  1
2008 Herring NR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT. Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology. 199: 637-50. PMID 18509623 DOI: 10.1007/s00213-008-1183-y  1
2008 Gudelsky GA, Yamamoto BK. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacology, Biochemistry, and Behavior. 90: 198-207. PMID 18035407 DOI: 10.1016/j.pbb.2007.10.003  1
2008 Schaefer TL, Skelton MR, Herring NR, Gudelsky GA, Vorhees CV, Williams MT. Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. Journal of Neurochemistry. 104: 1674-85. PMID 17996031 DOI: 10.1111/j.1471-4159.2007.05112.x  1
2008 Apparaju SK, Gudelsky GA, Desai PB. Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis. Cancer Chemotherapy and Pharmacology. 61: 223-9. PMID 17443325 DOI: 10.1007/s00280-007-0464-1  1
2007 Straiko MM, Gudelsky GA, Coolen LM. Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats. Behavioral Neuroscience. 121: 586-93. PMID 17592950 DOI: 10.1037/0735-7044.121.3.586  1
2007 Straiko MM, Coolen LM, Zemlan FP, Gudelsky GA. The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain. Neuroscience. 144: 223-31. PMID 17084036 DOI: 10.1016/j.neuroscience.2006.08.073  1
2006 Ehrman LA, Williams MT, Schaefer TL, Gudelsky GA, Reed TM, Fienberg AA, Greengard P, Vorhees CV. Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice. Genes, Brain, and Behavior. 5: 540-51. PMID 17010100 DOI: 10.1111/j.1601-183X.2006.00209.x  1
2006 Lindsay SE, Gudelsky GA, Heaton PC. Use of modafinil for the treatment of attention deficit/hyperactivity disorder. The Annals of Pharmacotherapy. 40: 1829-33. PMID 16954326 DOI: 10.1345/aph.1H024  1
2006 Schaefer TL, Ehrman LA, Gudelsky GA, Vorhees CV, Williams MT. Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. Journal of Neurochemistry. 98: 1369-78. PMID 16923155 DOI: 10.1111/j.1471-4159.2006.04034.x  1
2006 Straiko MM, Gudelsky GA, Coolen LM, Harrison R, Zemlan FP. Treatment with trimethyltin promotes the formation of cleaved tau in the rat brain. Journal of Neuroscience Research. 84: 1116-23. PMID 16917841 DOI: 10.1002/jnr.21002  1
2006 Nair SG, Gudelsky GA. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex. Brain Research Bulletin. 69: 382-7. PMID 16624669 DOI: 10.1016/j.brainresbull.2006.01.011  1
2006 Nair SG, Gudelsky GA. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology. 184: 182-9. PMID 16378215 DOI: 10.1007/s00213-005-0271-5  1
2006 Able JA, Gudelsky GA, Vorhees CV, Williams MT. 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biological Psychiatry. 59: 1219-26. PMID 16324685 DOI: 10.1016/j.biopsych.2005.09.006  1
2005 Nair SG, Gudelsky GA. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex. Synapse (New York, N.Y.). 58: 229-35. PMID 16206181 DOI: 10.1002/syn.20202  1
2005 Darvesh AS, Gudelsky GA. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. Brain Research. 1056: 168-75. PMID 16098955 DOI: 10.1016/j.brainres.2005.07.009  1
2005 Cohen MA, Skelton MR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood. Synapse (New York, N.Y.). 57: 148-59. PMID 15945064 DOI: 10.1002/syn.20166  1
2005 Williams MT, Schaefer TL, Ehrman LA, Able JA, Gudelsky GA, Sah R, Vorhees CV. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Research. 1039: 97-107. PMID 15781051 DOI: 10.1016/j.brainres.2005.01.045  1
2005 Darvesh AS, Yamamoto BK, Gudelsky GA. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 312: 694-701. PMID 15456837 DOI: 10.1124/jpet.104.074849  1
2004 Skelton MR, Blankenmeyer TL, Gudelsky GA, Brown-Strittholt CA, Vorhees CV, Williams MT. Metyrapone attenuates the sequential learning deficits but not monoamine depletions following d,l-fenfluramine administration to adult rats. Synapse (New York, N.Y.). 54: 214-22. PMID 15484208 DOI: 10.1002/syn.20077  1
2004 Nair SG, Gudelsky GA. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat. Synapse (New York, N.Y.). 53: 202-7. PMID 15266551 DOI: 10.1002/syn.20054  1
2004 Darvesh AS, Gudelsky GA. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats. Neurotoxicology and Teratology. 26: 571-7. PMID 15203179 DOI: 10.1016/  1
2004 Nair SG, Gudelsky GA. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat. Brain Research. 1013: 168-73. PMID 15193525 DOI: 10.1016/j.brainres.2004.04.007  1
2004 Matsuda M, Imaoka T, Vomachka AJ, Gudelsky GA, Hou Z, Mistry M, Bailey JP, Nieport KM, Walther DJ, Bader M, Horseman ND. Serotonin regulates mammary gland development via an autocrine-paracrine loop. Developmental Cell. 6: 193-203. PMID 14960274 DOI: 10.1016/S1534-5807(04)00022-X  1
2003 Williams MT, Blankenmeyer TL, Schaefer TL, Brown CA, Gudelsky GA, Vorhees CV. Long-term effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood. Brain Research. Developmental Brain Research. 147: 163-75. PMID 14741761 DOI: 10.1016/j.devbrainres.2003.11.001  1
2003 Hui AS, Striet JB, Gudelsky G, Soukhova GK, Gozal E, Beitner-Johnson D, Guo SZ, Sachleben LR, Haycock JW, Gozal D, Czyzyk-Krzeska MF. Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension. 42: 1130-6. PMID 14597643 DOI: 10.1161/01.HYP.0000101691.12358.26  1
2003 Zemlan FP, Mulchahey JJ, Gudelsky GA. Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: cleaved microtubule-associated protein-tau (C-tau). Neuroscience. 121: 399-409. PMID 14521998 DOI: 10.1016/S0306-4522(03)00459-7  1
2003 Darvesh AS, Gudelsky GA. Activation of 5-HT2 receptors induces glycogenolysis in the rat brain. European Journal of Pharmacology. 464: 135-40. PMID 12620505 DOI: 10.1016/S0014-2999(03)01432-8  1
2003 Wallace TL, Vorhees CV, Zemlan FP, Gudelsky GA. Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain. Neuroscience. 116: 1063-8. PMID 12617947 DOI: 10.1016/S0306-4522(02)00795-9  1
2003 Gudelsky GA, Yamamoto BK. Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods in Molecular Medicine. 79: 55-73. PMID 12506690  1
2002 Morford LL, Inman-Wood SL, Gudelsky GA, Williams MT, Vorhees CV. Impaired spatial and sequential learning in rats treated neonatally with D-fenfluramine. The European Journal of Neuroscience. 16: 491-500. PMID 12193193 DOI: 10.1046/j.1460-9568.2002.02100.x  1
2002 Darvesh AS, Shankaran M, Gudelsky GA. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 301: 138-44. PMID 11907167 DOI: 10.1124/jpet.301.1.138  1
2001 Nixdorf WL, Burrows KB, Gudelsky GA, Yamamoto BK. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate. Journal of Neurochemistry. 77: 647-54. PMID 11299327 DOI: 10.1046/j.1471-4159.2001.00262.x  1
2001 Wallace TL, Gudelsky GA, Vorhees CV. Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine. Psychopharmacology. 153: 321-6. PMID 11271404 DOI: 10.1007/s002130000578  1
2001 Shankaran M, Yamamoto BK, Gudelsky GA. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse (New York, N.Y.). 40: 55-64. PMID 11170222 DOI: 10.1002/1098-2396(200104)40:1<55::AID-SYN1026>3.0.CO;2-O  1
2001 Roberts RC. Effect of chronic olanzapine treatment on striatal synaptic organization. Synapse (New York, N.Y.). 39: 8-15. PMID 11071704 DOI: 10.1002/1098-2396(20010101)39:1<8::AID-SYN2>3.0.CO;2-K  1
2000 Harold C, Wallace T, Friedman R, Gudelsky G, Yamamoto B. Methamphetamine selectively alters brain glutathione. European Journal of Pharmacology. 400: 99-102. PMID 10913590 DOI: 10.1016/S0014-2999(00)00392-7  1
2000 Burrows KB, Gudelsky G, Yamamoto BK. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. European Journal of Pharmacology. 398: 11-8. PMID 10856443 DOI: 10.1016/S0014-2999(00)00264-8  1
1999 Shankaran M, Yamamoto BK, Gudelsky GA. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. European Journal of Pharmacology. 385: 103-10. PMID 10607865 DOI: 10.1016/S0014-2999(99)00728-1  1
1999 Gudelsky GA. Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat. Journal of Neural Transmission (Vienna, Austria : 1996). 106: 849-56. PMID 10599867 DOI: 10.1007/s007020050205  1
1999 Shankaran M, Gudelsky GA. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology. 147: 66-72. PMID 10591870 DOI: 10.1007/s002130051143  1
1999 Wallace TL, Gudelsky GA, Vorhees CV. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 9141-8. PMID 10516332  1
1999 Shankaran M, Yamamoto BK, Gudelsky GA. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum. Journal of Neurochemistry. 72: 2516-22. PMID 10349862 DOI: 10.1046/j.1471-4159.1999.0722516.x  1
1998 Shankaran M, Gudelsky GA. Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin. Pharmacology, Biochemistry, and Behavior. 61: 361-6. PMID 9802829 DOI: 10.1016/S0091-3057(98)00103-8  1
1996 Gudelsky GA. Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin. Journal of Neural Transmission (Vienna, Austria : 1996). 103: 1397-404. PMID 9029406 DOI: 10.1007/BF01271253  1
1996 Gudelsky GA, Nash JF. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. Journal of Neurochemistry. 66: 243-9. PMID 8522960  1
1995 Gudelsky GA. Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat. European Journal of Pharmacology. 286: 223-8. PMID 8608783 DOI: 10.1016/0014-2999(95)00415-8  1
1995 Yamamoto BK, Nash JF, Gudelsky GA. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. The Journal of Pharmacology and Experimental Therapeutics. 273: 1063-70. PMID 7791076  1
1994 Nichols DE, Frescas S, Marona-Lewicka D, Huang X, Roth BL, Gudelsky GA, Nash JF. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist. Journal of Medicinal Chemistry. 37: 4346-51. PMID 7996545  1
1994 Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA. Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neuroscience Letters. 177: 111-5. PMID 7824160 DOI: 10.1016/0304-3940(94)90057-4  1
1994 Gudelsky GA, Yamamoto BK, Nash JF. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. European Journal of Pharmacology. 264: 325-30. PMID 7698172 DOI: 10.1016/0014-2999(94)90669-6  1
1992 Meltzer HY, Gudelsky GA. Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile. Arzneimittel-Forschung. 42: 268-72. PMID 1586397  1
1992 Gudelsky GA, Nwajei EE, Defife K, Nash JF. Effects of amfonelic acid and GBR 12909 on the haloperidol- and clozapine-induced activation of dopamine neurons. Psychopharmacology Bulletin. 28: 275-9. PMID 1480731  1
1992 Stockmeier CA, Wingenfeld P, Gudelsky GA. Effects of repeated electroconvulsive shock on serotonin1A receptor binding and receptor-mediated hypothermia in the rat. Neuropharmacology. 31: 1089-94. PMID 1475018 DOI: 10.1016/0028-3908(92)90003-8  1
1992 Gudelsky GA, Nwajei EE, Defife K, Nash JF. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons. Synapse (New York, N.Y.). 12: 304-11. PMID 1361248 DOI: 10.1002/syn.890120407  1
1992 Berry SA, Gudelsky GA. Evidence for protein kinase-C mediation of the neurotensin-induced activation of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons. Endocrinology. 131: 1207-11. PMID 1354601 DOI: 10.1210/endo.131.3.1354601  1
1992 Gudelsky GA, Nash JF. Neuroendocrinological and neurochemical effects of sigma ligands. Neuropharmacology. 31: 157-62. PMID 1348112 DOI: 10.1016/0028-3908(92)90026-L  1
1991 Berry SA, Gudelsky GA. Effect of D2 dopamine agonists on tuberoinfundibular dopamine neurons. Neuropharmacology. 30: 961-5. PMID 1681453 DOI: 10.1016/0028-3908(91)90109-O  1
1990 Berry SA, Gudelsky GA. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons. The Journal of Pharmacology and Experimental Therapeutics. 254: 677-82. PMID 1974647  1
1990 Nash JF, Meltzer HY, Gudelsky GA. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens. Journal of Neurochemistry. 54: 1062-7. PMID 1689375  1
1989 Gudelsky GA, Nash JF, Berry SA, Meltzer HY. Basic biology of clozapine: electrophysiological and neuroendocrinological studies. Psychopharmacology. 99: S13-7. PMID 2682728 DOI: 10.1007/BF00442553  1
1989 Gudelsky GA, Berry SA, Meltzer HY. Actions of typical and atypical antipsychotics on tuberoinfundibular dopamine neurons. Psychopharmacology Bulletin. 25: 377-82. PMID 2576317  1
1989 Meltzer HY, Koenig JI, Nash JF, Gudelsky GA. Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs. Acta Psychiatrica Scandinavica. Supplementum. 352: 24-9. PMID 2573238  1
1989 Gudelsky GA, Meltzer HY. Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychotics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 2: 45-51. PMID 2572233  1
1989 Gudelsky GA, Berry SA, Meltzer HY. Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat. Neuroendocrinology. 49: 604-9. PMID 2549437  1
1989 Nash JF, Meltzer HY, Gudelsky GA. Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses. Pharmacology, Biochemistry, and Behavior. 33: 781-5. PMID 2533356 DOI: 10.1016/0091-3057(89)90470-X  1
1989 Gudelsky GA, Hippius H, Meltzer HY, Naber D. Summary of discussions Psychopharmacology. 99: S126-S127. DOI: 10.1007/BF00442577  1
1988 Gudelsky GA, Koenig JI, Koyama T, Meltzer HY. Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration. Psychopharmacology. 94: 92-6. PMID 3126532 DOI: 10.1007/BF00735887  1
1988 Nash JF, Meltzer HY, Gudelsky GA. Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat. European Journal of Pharmacology. 151: 463-9. PMID 2905661 DOI: 10.1016/0014-2999(88)90544-4  1
1988 Koenig JI, Meltzer HY, Gudelsky GA. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacology, Biochemistry, and Behavior. 29: 711-5. PMID 2901112 DOI: 10.1016/0091-3057(88)90192-X  1
1988 Nash JF, Meltzer HY, Gudelsky GA. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 245: 873-9. PMID 2898523  1
1987 Passaro EA, Meltzer HY, Gudelsky GA. Effects of acute and chronic dexamethasone treatment on stimulated prolactin secretion in the rat. Endocrine Research. 13: 173-82. PMID 3497800 DOI: 10.3109/07435808709023671  1
1987 Gudelsky GA, Koenig JI, Simonovic M, Koyama T, Ohmori T, Meltzer HY. Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat. Journal of Neural Transmission. 68: 227-40. PMID 3104536 DOI: 10.1007/BF02098500  1
1987 Gudelsky GA, Koenig JI, Meltzer HY. Selective desensitization of serotonin (5-HT) receptor-mediated hyperthermia by mianserin and other 5-HT antagonists. Neuropharmacology. 26: 707-12. PMID 2957607 DOI: 10.1016/0028-3908(87)90231-0  1
1987 Koenig JI, Gudelsky GA, Meltzer HY. Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. European Journal of Pharmacology. 137: 1-8. PMID 2956114 DOI: 10.1016/0014-2999(87)90175-0  1
1987 Gudelsky GA, Nash JF, Koenig JI, Meltzer HY. Neuroendocrine effects of typical and atypical antipsychotics in the rat Psychopharmacology Bulletin. 23: 483-486.  1
1986 Gudelsky GA, Passaro E, Meltzer HY. Delayed activation of tuberoinfundibular dopamine neurons and suppression of prolactin secretion in the rat after morphine administration. The Journal of Pharmacology and Experimental Therapeutics. 236: 641-5. PMID 3950867  1
1986 Gudelsky GA, Koenig JI, Meltzer HY. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology. 25: 1307-13. PMID 2951611 DOI: 10.1016/0028-3908(86)90101-2  1
1986 Gudelsky GA, Koenig JI, Jackman H, Meltzer HY. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors. Psychopharmacology. 90: 403-7. PMID 2947256 DOI: 10.1007/BF00179199  1
1986 Koenig JI, Meltzer HY, Gudelsky GA. Morphine or capsaicin administration alters the secretion of beta-endorphin into the hypophysial portal vasculature of the rat. Neuroendocrinology. 43: 611-7. PMID 2944026  1
1986 Koenig JI, Meltzer HY, Devane GD, Gudelsky GA. The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine. Endocrinology. 118: 2534-9. PMID 2938937 DOI: 10.1210/endo-118-6-2534  1
1986 Meltzer HY, Nash JF, Koenig JI, Gudelsky GA. Clozapine: neuroendocrine studies of an atypical neuroleptic. Clinical Neuropharmacology. 9: 316-8. PMID 2882843  1
1985 Locatelli V, Apud JA, Gudelsky GA, Cocchi D, Masotto C, Casanueva F, Racagni G, Müller EE. Prolactin in cerebrospinal fluid increases the synthesis and release of hypothalamic gamma-aminobutyric acid. The Journal of Endocrinology. 106: 323-8. PMID 4045339  1
1985 Meltzer HY, Simonovic M, Gudelsky GA. Phencyclidine-induced inhibition of rat prolactin secretion: increased portal blood dopamine. European Journal of Pharmacology. 110: 143-6. PMID 4007050 DOI: 10.1016/0014-2999(85)90042-1  1
1985 Gudelsky GA, Koenig JI, Meltzer HY. Altered responses to serotonergic agents in Fawn-Hooded rats. Pharmacology, Biochemistry, and Behavior. 22: 489-92. PMID 3158004 DOI: 10.1016/0091-3057(85)90052-8  1
1984 Mikuni M, Gudelsky GA, Simonovic M, Meltzer HY. Interaction of (+)- and (-)-3-PPP with the dopamine receptor in the anterior pituitary gland. Life Sciences. 34: 239-46. PMID 6694521 DOI: 10.1016/0024-3205(84)90595-2  1
1984 Gudelsky GA, Meltzer HY. Function of tuberoinfundibular dopamine neurons in pargyline- and reserpine-treated rats. Neuroendocrinology. 38: 51-5. PMID 6420718  1
1984 Simonovic M, Gudelsky GA, Meltzer HY. Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion. Journal of Neural Transmission. 59: 143-9. PMID 6233394 DOI: 10.1007/BF01255412  1
1984 Gudelsky GA, Simonovic M, Meltzer HY. Dopaminergic and serotonergic control of neuroendocrine function. Monographs in Neural Sciences. 10: 85-102. PMID 6142416  1
1983 Gudelsky GA, Passaro E, Meltzer HY. Effect of two dopamine agonists, TL-99 and 3-PPP, on prolactin secretion in the rat. European Journal of Pharmacology. 90: 423-5. PMID 6884430 DOI: 10.1016/0014-2999(83)90565-4  1
1983 Meltzer HY, Mikuni M, Simonovic M, Gudelsky GA. Effect of a novel benzamide, YM-09151-2, on rat serum prolactin levels. Life Sciences. 32: 1015-21. PMID 6827920 DOI: 10.1016/0024-3205(83)90933-5  1
1983 Gudelsky GA, Apud JA, Masotto C, Locatelli V, Cocchi D, Racagni G, Müller EE. Ethanolamine-O-sulfate enhances gamma-aminobutyric acid secretion into hypophysial portal blood and lowers serum prolactin concentrations. Neuroendocrinology. 37: 397-9. PMID 6646351 DOI: 10.1159/000123580  1
1983 Meltzer HY, Simonovic M, Gudelsky GA. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro. European Journal of Pharmacology. 92: 83-9. PMID 6628538 DOI: 10.1016/0014-2999(83)90111-5  1
1983 Meltzer HY, Simonovic M, Gudelsky GA. Effect of yohimbine on rat prolactin secretion. The Journal of Pharmacology and Experimental Therapeutics. 224: 21-7. PMID 6294278  1
1982 Meltzer HY, Simonovic M, Fang VS, Gudelsky GA. Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover. Psychopharmacology. 78: 49-53. PMID 6128756 DOI: 10.1007/BF00470587  1
1981 Nansel DD, Gudelsky GA, Reymond MJ, Porter JC. Estrogen alters the responsiveness of the anterior pituitary gland to the actions of dopamine on lysosomal enzyme activity and prolactin release. Endocrinology. 108: 903-7. PMID 7460850 DOI: 10.1210/endo-108-3-903  1
1981 Nansel DD, Gudelsky GA, Reymond MJ, Neaves WB, Porter JC. A possible role for lysosomes in the inhibitory action of dopamine on prolactin release. Endocrinology. 108: 896-902. PMID 7460849 DOI: 10.1210/endo-108-3-896  1
1981 Haskins JT, Gudelsky GA, Moss RL, Porter JC. Iontophoresis of morphine into the arcuate nucleus: effects on dopamine concentrations in hypophysial portal plasma and serum prolactin concentrations. Endocrinology. 108: 767-71. PMID 7460840 DOI: 10.1210/endo-108-3-767  1
1981 Gudelsky GA, Nansel DD, Porter JC. Dopaminergic control of prolactin secretion in the aging male rat. Brain Research. 204: 446-50. PMID 7459639 DOI: 10.1016/0006-8993(81)90606-5  1
1981 Gudelsky GA, Nansel DD, Porter JC. Role of estrogen in the dopaminergic control of prolactin secretion. Endocrinology. 108: 440-4. PMID 7449733 DOI: 10.1210/endo-108-2-440  1
1981 Gudelsky GA. Tuberoinfundibular dopamine neurons and the regulation of prolactin secretion. Psychoneuroendocrinology. 6: 3-16. PMID 7017786 DOI: 10.1016/0306-4530(81)90044-5  1
1981 Gudelsky GA, Porter JC. Sex-related difference in the release of dopamine into hypophysial portal blood. Endocrinology. 109: 1394-8. PMID 6795025 DOI: 10.1210/endo-109-5-1394  1
1981 Ackerman GE, MacDonald PC, Gudelsky G, Mendelson CR, Simpson ER. Potentiation of epinephrine-induced lipolysis by catechol estrogens and their methoxy derivatives. Endocrinology. 109: 2084-8. PMID 6273128 DOI: 10.1210/endo-109-6-2084  1
1980 Gudelsky GA, Nansel DD, Porter JC. Uptake and processing of dopamine by cells of the anterior pituitary gland. Endocrinology. 107: 30-4. PMID 7379751 DOI: 10.1210/endo-107-1-30  1
1980 Pilotte NS, Gudelsky GA, Porter JC. Relationship of prolactin secretion to dopamine release into hypophysial portal blood and dopamine turnover in the median eminence. Brain Research. 193: 284-8. PMID 7378822 DOI: 10.1016/0006-8993(80)90968-3  1
1980 Gudelsky GA, Porter JC. Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration. Endocrinology. 106: 526-9. PMID 7353525 DOI: 10.1210/endo-106-2-526  1
1980 Porter JC, Nansel DD, Gudelsky GA, Foreman MM, Pilotte NS, Parker CR, Burrows GH, Bates GW, Madden JD. Neuroendocrine control of gonadotropin secretion. Federation Proceedings. 39: 2896-901. PMID 6773815  1
1980 Porter JC, Dale Nansel D, Gudelsky GA, Reymond MJ, Pilotte NS, Foreman MM, Tilders FJH. Some aspects of hypothalamic and hypophysial secretion in aging rats Peptides. 1: 135-139. DOI: 10.1016/0196-9781(80)90111-4  1
1979 Gudelsky GA, Porter JC. Morphine- and opioid peptide-induced inhibition of the release of dopamine from tuberoinfundibular neurons. Life Sciences. 25: 1697-702. PMID 513974 DOI: 10.1016/0024-3205(79)90411-9  1
1979 Gudelsky GA, Porter JC. Release of newly synthesized dopamine into the hypophysial portal vasculature of the rat. Endocrinology. 104: 583-7. PMID 436715 DOI: 10.1210/endo-104-3-583  1
1979 Nansel DD, Gudelsky GA, Porter JC. Subcellular localization of dopamine in the anterior pituitary gland of the rat: apparent association of dopamine with prolactin secretory granules. Endocrinology. 105: 1073-7. PMID 226346 DOI: 10.1210/endo-105-5-1073  1
1979 Gudelsky GA, Porter JC. Prolactin and haloperidol stimulation of hypothalamic secretion of dopamine into pituitary stalk blood Federation Proceedings. 38: No. 5043.  1
1979 Nansel DD, Gudelsky GA, Porter JC. Subcellular localization of dopamine in the anterior pituitary gland of the rat: Apparent association of dopamine with the prolactin secretory granule Federation Proceedings. 38: No. 5044.  1
1978 Moore KE, Annunziato L, Gudelsky GA. Studies on tuberoinfundibular dopamine neurons. Advances in Biochemical Psychopharmacology. 19: 193-204. PMID 696461  1
1978 Gudelsky GA, Annunziato L, Moore KE. Localization of the site of the haloperidol-induced, prolactin-mediated increase of dopamine turnover in the median eminence: studies in rats with complete hypothalamic deafferentations. Journal of Neural Transmission. 42: 181-92. PMID 690628 DOI: 10.1007/BF01675309  1
1977 Moore KE, Gudelsky GA. Drug actions on dopamine turnover in the median eminence. Advances in Biochemical Psychopharmacology. 16: 227-35. PMID 883543  1
1977 Eikenburg DC, Ravitz AJ, Gudelsky GA, Moore KE. Effects of estrogen on prolactin and tuberoinfundibular dopaminergic neurons. Journal of Neural Transmission. 40: 235-44. PMID 881623 DOI: 10.1007/BF01257017  1
1977 Gudelsky GA, Moore KE. A comparison of the effects of haloperidol on dopamine turnover in the striatum, olfactory tubercule and median eminence. The Journal of Pharmacology and Experimental Therapeutics. 202: 149-56. PMID 874811  1
1977 Gudelsky GA, Annunziato L, Moore KE. Increase in dopamine content of the rat median eminence after long-term ovariectomy and its reversal by estrogen replacement. Endocrinology. 101: 1894-7. PMID 588327 DOI: 10.1210/endo-101-6-1894  1
1977 Annunziato L, Gudelsky GA, Moore KE. The effects of hypothalamic deafferentation on the haloperidol induced activation of tuberoinfundibular dopamine neurons Pharmacologist. 19: No. 542.  1
1977 Gudelsky GA, Annunziato L, Ravitz AJ. Effects of estrogen on serum prolactin levels and dopamine turnover in nigrostriatal and tuberoinfundibular neurons of the rat Federation Proceedings. 36: No. 41.  1
1976 Gudelsky GA, Moore EK. Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum. Journal of Neural Transmission. 38: 95-105. PMID 1271052 DOI: 10.1007/BF01262968  1
1976 Gudelsky GA, Simpkins J, Mueller GP, Meites J, Moore KE. Selective actions of prolactin on catecholamine turnover in the hypothalamus and on serum LH and FSH. Neuroendocrinology. 22: 206-15. PMID 1028951  1
1976 Gudelsky GA, Moore KE. Differential drug effects on the tuberoinfundibular, mesolimbic and nigrostriatal dopaminergic neurons of the rat Pharmacologist. 18: No.119.  1
1975 Gudelsky GA, Thornburg JE, Moore KE. Blockade of alpha-methyltyrosine-induced supersensitivity to apomorphine by chronic administration of L-dopa. Life Sciences. 16: 1331-8. PMID 1134198 DOI: 10.1016/0024-3205(75)90318-5  1
1974 Gudelsky GA, McCall RB, Chiueh CC, Moore KE. Lack of effect of amantadine on d-amphetamine-induced release of dopamine from cat brain in vivo. Research Communications in Chemical Pathology and Pharmacology. 9: 653-60. PMID 4456497  1
1974 Rech RH, Gudelsky G. Interactions between Ro4 1284 and d amphetamine (dA) on shuttle box avoidance in rats Pharmacologist. 16: No. 665.  1
Show low-probability matches.